Poissy, Julien http://orcid.org/0000-0001-6017-5353
,
Damonti, Lauro
Bignon, Anne
Khanna, Nina
Von Kietzell, Matthias
Boggian, Katia
Neofytos, Dionysios
Vuotto, Fanny
Coiteux, Valérie
Artru, Florent
Zimmerli, Stephan
Pagani, Jean-Luc
Calandra, Thierry
Sendid, Boualem
Poulain, Daniel
van Delden, Christian
Lamoth, Frédéric
Marchetti, Oscar
Bochud, Pierre-Yves
,
Funding for this research was provided by:
swiss national foundation (324730-144054 and 33IC30_179636)
European Union’s Seventh Framework Program (HEALTH-2010–260338)
Article History
Received: 1 November 2019
Accepted: 7 February 2020
First Online: 18 March 2020
Ethics approval and consent to participate
: All patients gave written informed consent before participation in the study. Written informed consent was waived by the patients’ legal representative in the case of incapacity before inclusion. The protocol was approved by the Institutional Review Board of Lille University Hospital “Comité de Protection des Personnes Nord Ouest IV” and by the Swiss Network of Ethics Committees. The study was registered on ClinicalTrials.gov (NCT02841501).
: Not applicable
: TC has been in an advisory board for Astellas, Basilea, Cidara, MSD, Sobi, Thermofisher, GE Healthcare, and in a Data Monitoring Board for Novartis. The other authors declare that they have no conflict of interest.